EVG Evgen Pharma Plc

 

TIDMEVG 
 
RNS Number : 3985G 
Evolution Group PLC 
01 February 2010 
 

 
 
Embargoed until 7.00am 1 February 2010 
 
 
 
 
 
 
                            The Evolution Group PLC 
              (the "Evolution Group", the "Group", the "Company") 
 Pre-close Trading Update 
 
 
Evolution Group, the listed investment bank and private client investment 
management group, today issues its pre-close trading update for the financial 
year ending 31 December 2009. 
 
 
The Group's strong performance continued into the final quarter with full year 
revenues more than double the previous year. Full year earnings are expected to 
be in line with market expectations. This strong performance reflects 
significant revenue momentum in all our businesses in the second half. 
 
 
While the challenging economic conditions of 2009 clearly remain with us in 
early 2010, we remain focused on our strategy of continued growth and financial 
strength. 
 
 
Forward looking statements 
 
 
This pre-close statement may contain forward-looking statements with respect to 
the financial condition, results, operations and businesses of The Evolution 
Group PLC. Such statements and forecasts involve risk and uncertainty because 
they relate to events and depend upon circumstances that will occur in the 
future. There are a number of factors that could cause actual results or 
developments to differ materially from those expressed or implied by 
forward-looking statements and forecasts. Forward-looking statements and 
forecasts are based on the Directors' current view and information known to them 
at the date of this statement. The Directors do not make any undertaking to 
update or revise any forward-looking statements, whether as a result of new 
information, future events or otherwise. Nothing in this pre-close 
statement should be construed as a profit forecast. 
 
 
-Ends- 
 
For further information, please contact: 
 
 
+---------------------------------------------------+------------------------+ 
| The Evolution Group PLC                           | 020 7071 4300          | 
| Alex Snow, Chief Executive Officer                |                        | 
| Andrew Westenberger, Finance Director             |                        | 
+---------------------------------------------------+------------------------+ 
|                                                   |                        | 
+---------------------------------------------------+------------------------+ 
| Pelham Bell Pottinger                             | 020 7337 1546          | 
| Charles Cook                                      |                        | 
| Emma Kent                                         |                        | 
| Victoria Geoghegan                                |                        | 
+---------------------------------------------------+------------------------+ 
 
 
Notes to Editors: 
 
 
The Evolution Group PLC 
The Evolution Group is the holding company of Evolution Securities Limited 
and Williams de Broë Limited.  Founded in April 2001 and originally listed on 
AIM, the Evolution Group joined the LSE Official List in 2003 and re-entered the 
FTSE 250 in 2009, the Group now has a market capitalisation of 
approximately GBP300 million. 
 
 
 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 TSTBRGDBUBDBGGC 
 

Grafico Azioni Evgen Pharma (LSE:EVG)
Storico
Da Giu 2024 a Lug 2024

Grafico Azioni Evgen Pharma (LSE:EVG)
Storico
Da Lug 2023 a Lug 2024